查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1828137

2025年全球內部神經調節設備市場報告

Internal Neuromodulation Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體內神經調節設備的市場規模呈現強勁成長勢頭，從2024年的25.9億美元增至2025年的27.5億美元，複合年成長率為6.0%。預測期內的成長可歸因於慢性疼痛管理、人口老化、臨床研究和測試、神經系統疾病的流行以及患者的認知和接受度。

預計未來幾年，內部神經調節設備市場規模將強勁成長，2029年將達到38.7億美元，複合年成長率為8.9%。預測期內的成長可歸因於個人化醫療趨勢、醫療保健支出的增加、合作研究與夥伴關係關係、患者治療效果和真實世界證據以及監管格局的變化。預測期內的主要趨勢包括微型化和可用技術、無線連接和遠端監控、神經調節應用的不斷擴展、用於精確調節的閉合迴路系統以及對以患者為中心的設計的關注。

內部神經調節裝置是一類透過手術植入體內的醫療設備，為神經系統的特定部位提供電刺激，以緩解各種神經和精神症狀。

體內神經調節裝置的主要類型包括脊髓刺激設備、深層腦部刺激器、薦骨神經刺激器、迷走神經刺激設備和胃神經刺激設備。這些裝置採用多種技術，包括體內和體外神經調節，以及金屬生物材料、聚合物生物材料和陶瓷生物材料等生物材料。這些裝置用於治療腰椎手術失敗症候群、帕金森氏症、尿失禁、癲癇和胃輕癱等疾病。這些裝置的最終用戶包括醫院、診所、家庭醫療保健和社區醫療保健。

2025年春季，美國關稅飆升及其引發的貿易摩擦對醫療設備產業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場准入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供內部神經調節劑市場統計數據，例如全球市場規模、區域佔有率、內部神經調節劑市場佔有率的競爭對手、詳細的內部神經調節劑細分市場、市場趨勢和商業機會，以及在內部神經調節劑行業取得成功所需的數據。本內部神經調節劑市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切資訊的完整觀點。

我們預測未來五年該市場將成長8.9%，較先前預測略有下降0.3%。下降主要源自於美國與其他國家之間關稅的影響。這種影響可能會直接波及美國，導致可充電神經刺激設備電池和定向導線陣列的供應鏈中斷，這些產品主要來自英國和加拿大等主要地區，這可能導致慢性疼痛治療​​的延遲和神經系統治療成本的增加。此外，由於互惠關稅以及貿易緊張局勢和限制措施升級對全球經濟和貿易的負面影響，這種影響也將更加廣泛地蔓延。

神經系統疾病盛行率的上升預計將推動體內神經調節設備市場的成長。神經系統疾病涵蓋多種影響神經系統的疾病，包括大腦、脊髓和周邊神經。體內神經調節設備透過向神經系統的特定部位施加定向電刺激來治療神經系統和精神疾病，以緩解慢性疼痛、運動障礙和情緒障礙等症狀。透過減輕症狀，這些設備可以改善患者的生活品質，並促進日常活動的進行。例如，2023年4月，美國生物醫學圖書館國家醫學圖書館報告稱，670萬美國患有阿茲海默症，並預測到2060年這一數字將達到1,380萬人。此外，2022年5月，英國上議院圖書館報告稱，截至2022年1月31日，英格蘭共有1638名全職神經病學工作人員，高於2021年的1562名和2020年的1468名。因此，神經系統疾病盛行率的不斷上升正在推動內部神經調節設備市場的擴張。

腦腫瘤發生率的上升預計將推動內部神經調節劑市場的擴張。腦腫瘤是一類發生在腦部和脊髓的腫瘤，其複雜性和治療難度都很大。內部神經調節劑已成為治療各種腦部疾病的有前景的解決方案，它透過直接向特定腦區傳遞電刺激或其他形式的能量來調節神經元活動並產生治療效果。美國腦腫瘤協會報告稱，2022年將有約94,390名美國被診斷出患有腦腫瘤，預計2023年將有18,990人死於惡性腦腫瘤。因此，腦腫瘤發生率的上升是內部神經調節劑市場成長的催化劑。

產品創新是內部神經調節設備市場的一個顯著趨勢。該領域的主要企業正在積極開發新技術以保持其市場地位。例如，2023年3月，總部位於愛爾蘭的醫療設備製造商Neuromod Device Ltd.宣布其Lenire系統獲得美國食品藥物管理局(FDA)的De novo批准。 Lenire系統結合了聲音刺激和舌頭刺激來治療耳鳴，這是一種以耳鳴為特徵的神經系統疾病。此創新系統採用雙管齊下的神經刺激方法：利用藍牙耳機播放獨特的聲音來刺激聽覺神經，同時Neuromod的Tonguetip設備向舌頭表面傳遞適度的電脈衝。這項技術為耳鼻喉科醫生提供了一種創新工具，可以推薦給生活中受到中度至重度耳鳴影響的患者。

為了獲得競爭優勢，內部神經調節設備市場的主要企業正專注於開創性的技術創新，包括數位健康應用程式。數位健康應用程式旨在為用戶在行動裝置上提供健康相關服務和資訊的軟體應用程式。例如，2022年7月，美國醫療設備供應商雅培實驗室推出了Neurosphere Virtual Clinic，這是一項突破性的技術，使配備雅培神經刺激設備的患者能夠與醫生進行遠端溝通。此功能可讓患者透過安全的應用程式內視訊聊天和整合的遠端編程來確認正確的設定和功能，或接收新的治療設定。該平台為醫生提供有關患者設備使用和疼痛程度的即時數據。

2022年3月，美國醫療器材製造商Electro 醫療設備 Products International (EPI)收購了Pulvinar Neuro，收購金額未揭露。此次收購增強了Pulvinar Neuro的實力，使其能夠推進其專利技術，包括經顱交流電刺激(tACS)。此外，此次收購還增強了其針對精神和神經系統疾病的雲端數位化治療以及客製化回饋刺激技術。 Pulvinar Neuro是一家總部位於美國的醫療科技公司，專注於開發用於治療神經和精神疾病的深部腦部刺激(DBS)系統。

在內部神經調節設備市場中營運的主要企業包括美敦力公司、波士頓科學公司、BioControl Medical Ltd.、Aleva Neurotherapeutics SA、Bioness Inc.、Uroplasty Inc.、雅培實驗室、EnteroMedics Inc.、LivaNova plc、NeuroPace Inc.、Synapse Biomedical Inc.、Soterixave Inc.、Neurox Medical、Neurot、St團Incorporated、SPR Therapeutics、Axonics Modulation Technologies Inc.、Saluda Medical Pty Limited、MicroTransponder Inc.、EndoStim Inc.、NeuroMetrix Inc.、Second Sight Medical Products Inc.、Neurotech International Limited、Neuronix Ltd. 和 Neuronoff Inc.

2024年，北美將成為體內神經調節設備市場最大的地區。根據全球體內神經調節設備市場報告，預計亞太地區將成為預測期內成長最快的地區。體內神經調節設備市場報告涵蓋亞太地區、西歐、中歐和東歐、北美、南美以及中東和非洲。

內部神經調節設備市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

內部神經調節設備市場包括電極、導線、接收器和其他產品的銷售。該市場的價值指的是“出廠價”，即產品製造商或生產商銷售給其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接銷售給最終客戶的價值。該市場中的產品價值還包括產品製造商銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球內部神經調節器：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球內部神經調節設備市場：成長率分析
  • 全球內部神經調節設備市場表現：規模與成長，2019-2024
  • 全球內部神經調節設備市場預測：規模與成長，2024-2029，2034
  • 全球內部神經調節劑：總目標市場（TAM）

第6章 市場細分

  • 全球內部神經調節設備市場類型、表現及預測（2019-2024、2024-2029、2034）
  • 脊髓刺激設備
  • 深層腦部刺激器
  • 薦骨神經刺激器
  • 迷走神經刺激設備
  • 胃神經刺激設備
  • 全球內部神經調節設備市場（按技術類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 內部神經調節
  • 外部神經調節
  • 全球內部神經調節設備市場（按生物材料、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 金屬生物材料
  • 聚合物生物材料
  • 陶瓷生物材料
  • 全球內部神經調節設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 背部手術失敗綜合症
  • 帕金森氏症
  • 尿失禁
  • 癲癇
  • 胃輕癱
  • 全球內部神經調節設備市場（按最終用戶、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 家庭醫療保健
  • 社區醫療保健
  • 全球內部神經調節設備市場：脊髓刺激設備細分市場，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 常規脊髓刺激設備
  • 可充電脊髓刺激設備
  • 非充電脊髓刺激設備
  • 全球內部神經調節設備市場：深層腦部刺激器細分，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 單導程深層腦部刺激器
  • 雙導聯深部腦部刺激器
  • 自適應深層腦部刺激器
  • 全球內部神經調節設備市場：薦骨神經刺激器細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式薦骨神經刺激器
  • 外部薦骨神經刺激器
  • 全球內部神經調節設備市場：迷走神經刺激設備細分市場，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式迷走神經刺激設備
  • 經皮迷走神經刺激設備
  • 全球內部神經調節設備市場：胃神經刺激設備細分市場，按類型、表現和預測，2019-2024 年、2024-2029 年、2034 年
  • 植入式胃神經刺激設備
  • 外部胃神經刺激設備

第7章 區域和國家分析

  • 全球內部神經調節設備市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球內部神經調節設備市場：國家、績效與預測，2019-2024、2024-2029、2034

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 內部神經調節設備市場：競爭格局
  • 內部神經調節設備市場：公司簡介
    • Medtronic plc
    • Boston Scientific Corporation
    • BioControl Medical Ltd.
    • Aleva Neurotherapeutics SA
    • Bioness Inc.

第31章：其他領先和創新企業

  • Uroplasty Inc.
  • Abbott Laboratories
  • EnteroMedics Inc.
  • LivaNova plc
  • NeuroPace Inc.
  • Synapse Biomedical Inc.
  • Soterix Medical Inc.
  • Neuros Medical Inc.
  • Nevro Corp.
  • Nuvectra Corporation
  • Stimwave Technologies Incorporated
  • SPR Therapeutics
  • Axonics Modulation Technologies Inc.
  • Saluda Medical Pty Limited
  • MicroTransponder Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029年內部神經調節設備市場：提供新機會的國家
  • 2029年內部神經調節設備市場：細分市場帶來新機會
  • 2029年內部神經調節設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r24244u

Internal neuromodulation devices are a category of medical devices that are surgically implanted inside the body to deliver electrical stimulation to specific areas of the nervous system, offering relief for various neurological and psychiatric conditions.

The primary types of internal neuromodulation devices include spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and gastric neurostimulators. These devices utilize different technologies, encompassing both internal and external neuromodulation, along with biomaterials such as metallic biomaterials, polymeric biomaterials, and ceramic biomaterials. They find applications in treating conditions such as failed back surgery syndrome, Parkinson's disease, urinary incontinence, epilepsy, and gastroparesis. The end-users of these devices span hospitals, clinics, home healthcare, and community healthcare.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The internal neuromodulation devices market research report is one of a series of new reports from The Business Research Company that provides internal neuromodulation devices market statistics, including internal neuromodulation devices industry global market size, regional shares, competitors with a internal neuromodulation devices market share, detailed internal neuromodulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the internal neuromodulation devices industry. This internal neuromodulation devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The internal neuromodulation devices market size has grown strongly in recent years. It will grow from $2.59 billion in 2024 to $2.75 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to chronic pain management, aging population, clinical research and trials, neurological disorders prevalence, patient awareness and acceptance.

The internal neuromodulation devices market size is expected to see strong growth in the next few years. It will grow to $3.87 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to personalized medicine trends, rising healthcare expenditure, collaborations and partnerships, patient outcomes and real-world evidence, regulatory landscape changes. Major trends in the forecast period include miniaturization and implantable technology, wireless connectivity and remote monitoring, expanded applications for neuromodulation, closed-loop systems for precise modulation, focus on patient-centric design.

The forecast of 8.9% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for rechargeable neurostimulator batteries and directional lead arrays, sourced from key regions such as the UK and Canada, which could lead to delayed chronic pain treatments and increased costs for neurological therapies.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of neurological diseases is anticipated to drive growth in the internal neuromodulation devices market. Neurological diseases encompass a wide range of disorders that impact the nervous system, including the brain, spinal cord, and peripheral nerves. Internal neuromodulation devices are used to treat neurological and psychiatric conditions by delivering targeted electrical stimulation to specific parts of the nervous system, helping to alleviate symptoms like chronic pain, movement disorders, and mood disorders. These devices can enhance patients' quality of life by reducing symptoms, making it easier for them to carry out daily tasks. For example, in April 2023, the National Library of Medicine, a U.S.-based biomedical library, reported that 6.7 million Americans are living with Alzheimer's, a number projected to reach 13.8 million by 2060. Additionally, in May 2022, the House of Lords Library in the UK reported that as of January 31, 2022, there were 1,638 full-time equivalent staff in England's neurology workforce, up from 1,562 in 2021 and 1,468 in 2020. Consequently, the increasing prevalence of neurological diseases is fueling the expansion of the internal neuromodulation devices market.

The rising incidence of brain cancers is anticipated to fuel the expansion of the internal neuromodulation devices market. Brain cancer, a diverse group of tumors originating in the brain or spinal cord, poses complex challenges for understanding and treatment. Internal neuromodulation devices emerge as a promising therapeutic solution for various brain disorders, delivering electrical stimulation or other forms of energy directly to specific brain regions to modulate neuronal activity and induce therapeutic effects. In 2022, the National Brain Tumor Society reported an expected diagnosis of brain tumors in approximately 94,390 Americans, with an estimated 18,990 deaths from malignant brain tumors in 2023. Thus, the growing incidence of brain cancers serves as a catalyst for the growth of the internal neuromodulation devices market.

A prominent trend gaining traction in the internal neuromodulation devices market is product innovation. Major companies in this segment are actively engaged in developing new technologies to maintain their market positions. For instance, in March 2023, Ireland-based medical equipment manufacturer Neuromod Device Ltd. announced that its Lenire system had received De Novo clearance from the US Food and Drug Administration (FDA). The Lenire system employs a combination of sound stimulation and tongue stimulation to treat tinnitus, a neurological disorder characterized by ringing in the ears. This innovative system uses a dual-pronged approach to neurostimulation, utilizing Bluetooth headphones to play unique sounds stimulating the auditory nerve, while Neuromod's Tonguetip device transmits moderate electrical stimulation to the tongue's surface. This technology provides otolaryngologists with an innovative tool to recommend to patients experiencing a moderately negative impact on their lives due to tinnitus.

Major companies in the internal neuromodulation devices market are concentrating on developing technological innovations, including digital health apps, to gain a competitive edge. Digital health apps are software applications designed to deliver health-related services and information to users on mobile devices. For example, in July 2022, US-based medical device provider Abbott Laboratories launched the NeuroSphere Virtual Clinic, a groundbreaking technology allowing patients with Abbott's neurostimulation devices to remotely communicate with doctors. This feature enables patients to ensure proper settings, functionality, and receive new treatment settings via secure in-app video chat and integrated remote programming. The platform provides real-time data to physicians about patients' device usage and pain levels.

In March 2022, US-based medical equipment manufacturer Electromedical Products International (EPI) acquired Pulvinar Neuro for an undisclosed amount. Through this acquisition, Pulvinar Neuro gains enhanced capabilities for promoting its patented technologies, such as transcranial alternating current stimulation (tACS). Additionally, the acquisition enhances its cloud-enabled digital treatments for mental and neurological conditions and customized feedback stimulation. Pulvinar Neuro is a US-based medical technology company specializing in deep brain stimulation (DBS) systems for treating neurological and psychiatric disorders.

Major companies operating in the internal neuromodulation devices market include Medtronic plc, Boston Scientific Corporation, BioControl Medical Ltd., Aleva Neurotherapeutics SA, Bioness Inc., Uroplasty Inc., Abbott Laboratories, EnteroMedics Inc., LivaNova plc, NeuroPace Inc., Synapse Biomedical Inc., Soterix Medical Inc., Neuros Medical Inc., Nevro Corp., Nuvectra Corporation, Stimwave Technologies Incorporated, SPR Therapeutics, Axonics Modulation Technologies Inc., Saluda Medical Pty Limited, MicroTransponder Inc., EndoStim Inc., NeuroMetrix Inc., Second Sight Medical Products Inc., Neurotech International Limited, Neuronix Ltd., Neuronoff Inc.

North America was the largest region in the internal neuromodulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global internal neuromodulation devices market report during the forecast period. The regions covered in the internal neuromodulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the internal neuromodulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The internal neuromodulation devices market consists of sales of electrodes, leads, receivers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Internal Neuromodulation Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on internal neuromodulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for internal neuromodulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The internal neuromodulation devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Technology Type: Internal Neuromodulation; External Neuromodulation
  • 3) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 4) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 5) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Subsegments:
  • 1) By Spinal Cord Stimulator: Traditional Spinal Cord Stimulator; Rechargeable Spinal Cord Stimulator; Non-Rechargeable Spinal Cord Stimulator
  • 2) By Deep Brain Stimulator: Single Lead Deep Brain Stimulator; Dual Lead Deep Brain Stimulator; Adaptive Deep Brain Stimulator
  • 3) By Sacral Nerve Stimulator: Implantable Sacral Nerve Stimulator; External Sacral Nerve Stimulator
  • 4) By Vagus Nerve Stimulator: Implantable Vagus Nerve Stimulator; Transcutaneous Vagus Nerve Stimulator
  • 5) By Gastric Neuro Stimulator: Implantable Gastric Neuro Stimulator; External Gastric Neuro Stimulator
  • Companies Mentioned: Medtronic plc; Boston Scientific Corporation; BioControl Medical Ltd.; Aleva Neurotherapeutics SA; Bioness Inc.; Uroplasty Inc.; Abbott Laboratories; EnteroMedics Inc.; LivaNova plc; NeuroPace Inc.; Synapse Biomedical Inc.; Soterix Medical Inc.; Neuros Medical Inc.; Nevro Corp.; Nuvectra Corporation; Stimwave Technologies Incorporated; SPR Therapeutics; Axonics Modulation Technologies Inc.; Saluda Medical Pty Limited; MicroTransponder Inc.; EndoStim Inc.; NeuroMetrix Inc.; Second Sight Medical Products Inc.; Neurotech International Limited; Neuronix Ltd.; Neuronoff Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Internal Neuromodulation Devices Market Characteristics

3. Internal Neuromodulation Devices Market Trends And Strategies

4. Internal Neuromodulation Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Internal Neuromodulation Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Internal Neuromodulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Internal Neuromodulation Devices Market Growth Rate Analysis
  • 5.4. Global Internal Neuromodulation Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Internal Neuromodulation Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Internal Neuromodulation Devices Total Addressable Market (TAM)

6. Internal Neuromodulation Devices Market Segmentation

  • 6.1. Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Neuro Stimulator
  • 6.2. Global Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Internal Neuromodulation
  • External Neuromodulation
  • 6.3. Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • 6.4. Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Failed Back Surgery Syndrome
  • Parkinson's Disease
  • Urinary Incontinence
  • Epilepsy
  • Gastroparesis
  • 6.5. Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Home Healthcare
  • Community Healthcare
  • 6.6. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Traditional Spinal Cord Stimulator
  • Rechargeable Spinal Cord Stimulator
  • Non-Rechargeable Spinal Cord Stimulator
  • 6.7. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Deep Brain Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Lead Deep Brain Stimulator
  • Dual Lead Deep Brain Stimulator
  • Adaptive Deep Brain Stimulator
  • 6.8. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Sacral Nerve Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Sacral Nerve Stimulator
  • External Sacral Nerve Stimulator
  • 6.9. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Vagus Nerve Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Vagus Nerve Stimulator
  • Transcutaneous Vagus Nerve Stimulator
  • 6.10. Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Gastric Neuro Stimulator, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Implantable Gastric Neuro Stimulator
  • External Gastric Neuro Stimulator

7. Internal Neuromodulation Devices Market Regional And Country Analysis

  • 7.1. Global Internal Neuromodulation Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Internal Neuromodulation Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Internal Neuromodulation Devices Market

  • 8.1. Asia-Pacific Internal Neuromodulation Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Internal Neuromodulation Devices Market

  • 9.1. China Internal Neuromodulation Devices Market Overview
  • 9.2. China Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Internal Neuromodulation Devices Market

  • 10.1. India Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Internal Neuromodulation Devices Market

  • 11.1. Japan Internal Neuromodulation Devices Market Overview
  • 11.2. Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Internal Neuromodulation Devices Market

  • 12.1. Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Internal Neuromodulation Devices Market

  • 13.1. Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Internal Neuromodulation Devices Market

  • 14.1. South Korea Internal Neuromodulation Devices Market Overview
  • 14.2. South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Internal Neuromodulation Devices Market

  • 15.1. Western Europe Internal Neuromodulation Devices Market Overview
  • 15.2. Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Internal Neuromodulation Devices Market

  • 16.1. UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Internal Neuromodulation Devices Market

  • 17.1. Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Internal Neuromodulation Devices Market

  • 18.1. France Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Internal Neuromodulation Devices Market

  • 19.1. Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Internal Neuromodulation Devices Market

  • 20.1. Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Internal Neuromodulation Devices Market

  • 21.1. Eastern Europe Internal Neuromodulation Devices Market Overview
  • 21.2. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Internal Neuromodulation Devices Market

  • 22.1. Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Internal Neuromodulation Devices Market

  • 23.1. North America Internal Neuromodulation Devices Market Overview
  • 23.2. North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Internal Neuromodulation Devices Market

  • 24.1. USA Internal Neuromodulation Devices Market Overview
  • 24.2. USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Internal Neuromodulation Devices Market

  • 25.1. Canada Internal Neuromodulation Devices Market Overview
  • 25.2. Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Internal Neuromodulation Devices Market

  • 26.1. South America Internal Neuromodulation Devices Market Overview
  • 26.2. South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Internal Neuromodulation Devices Market

  • 27.1. Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Internal Neuromodulation Devices Market

  • 28.1. Middle East Internal Neuromodulation Devices Market Overview
  • 28.2. Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Internal Neuromodulation Devices Market

  • 29.1. Africa Internal Neuromodulation Devices Market Overview
  • 29.2. Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Internal Neuromodulation Devices Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Internal Neuromodulation Devices Market Competitive Landscape And Company Profiles

  • 30.1. Internal Neuromodulation Devices Market Competitive Landscape
  • 30.2. Internal Neuromodulation Devices Market Company Profiles
    • 30.2.1. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. BioControl Medical Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Aleva Neurotherapeutics SA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Bioness Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Internal Neuromodulation Devices Market Other Major And Innovative Companies

  • 31.1. Uroplasty Inc.
  • 31.2. Abbott Laboratories
  • 31.3. EnteroMedics Inc.
  • 31.4. LivaNova plc
  • 31.5. NeuroPace Inc.
  • 31.6. Synapse Biomedical Inc.
  • 31.7. Soterix Medical Inc.
  • 31.8. Neuros Medical Inc.
  • 31.9. Nevro Corp.
  • 31.10. Nuvectra Corporation
  • 31.11. Stimwave Technologies Incorporated
  • 31.12. SPR Therapeutics
  • 31.13. Axonics Modulation Technologies Inc.
  • 31.14. Saluda Medical Pty Limited
  • 31.15. MicroTransponder Inc.

32. Global Internal Neuromodulation Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Internal Neuromodulation Devices Market

34. Recent Developments In The Internal Neuromodulation Devices Market

35. Internal Neuromodulation Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Internal Neuromodulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Internal Neuromodulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Internal Neuromodulation Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer